"Our new corporate name leverages the tremendous goodwill and name recognition that we have achieved in Europe and North America for our EOS orthopedic imaging system," said Marie Meynadier, Ph.D., CEO of EOS imaging."EOS is clearly changing the way radiologist/orthopedist teams can now diagnose and treat deformative and degenerative pathologies in all age groups, from children to geriatric patients. Without EOS, radiologists and orthopedists have to interpret what they're looking at in a 2D x-ray. Now, with EOS, they can have a complete view of their patient's skeletal anatomy: life-sized, standing up, and in 3D from all angles. EOS imaging is working to establish EOS as a new modality in orthopedic imaging, with very low X-ray exposure1 to the patient and efficient patient workflow for the physician," added Dr. Meynadier.
"Among radiologists and orthopedists, EOS has now become synonymous with upright, full-body, ultra-low-dose images due to its uniqueness in the medical imaging market," said Hervé Legrand, Vice President of Marketing for EOS imaging. "Orthopedic surgeons are prescribing an EOS exam as they would order an X-ray, a CT scan, or an MRI exam. As a result of this strong branding of EOS, It is logical for us to align our flagship product name with our company name, EOS imaging."
About the product and the company EOS imaging
EOSwas developed from a Nobel Prize-winning technology by a team of engineers, orthopedic surgeons and radiologists as a complete orthopedic imaging solution. EOS allows full-body imaging of patients that enables global assessment of balance and posture as well as a 3D bone-envelope image in a weight-bearing position, and provides automatically over 100 clinical parameters to the orthopedic surgeon for pre- and post-operative surgical planning. EOS is a total solution in orthopedic imaging available in the U.S. since receiving FDA 510(k) clearance. The company EOS Imaging has corporate headquarters in Cambridge, Mass. (185 Alewife Brook Parkway, Suite 410; toll-free: +1-866-933-5301), and Paris, as well as an office in Montreal, and is targeting a $2 billion orthopedic imaging marketplace.
